Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: A phase II TCOG study

Abstract

Celecoxib can be safely combined with preoperative CRT for rectal cancer. More intensified adjuvant therapy may be considered for tumors expressing high-level COX-2 after CRT and surgery.